MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH KNOW-HOW LICENSE AGREEMENTKnow-How License Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus • Minnesota
This know-how license agreement (“Agreement”), made as of this 24th day of January 2022 (the “Effective Date”), is by and between Mayo Foundation for Medical Education and Research, a Minnesota charitable corporation, located at 200 First Street SW, Rochester, Minnesota 55905 (“MAYO”), and Viewpoint Molecular Targeting Inc., a Delaware Corporation, having a place of business at 2500 Crosspark Road, E116, Coralville, IA 52241 (“COMPANY”), each may be referred to as a “Party,” and collectively as the “Parties.”
LEASE DOCUMENT FOR THE UNIVERSITY OF IOWA BIOVENTURES CENTERchLease Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus • Iowa
THE LEASE MADE AND ENTERED INTO THIS 21st day of February , 2023, by and between Board of Regents, State of Iowa, for the use and benefit of the University of Iowa, hereinafter referred to as LESSOR, and Viewpoint Molecular Targeting, hereinafter referred to as the LESSEE. LESSOR and LESSEE are jointly referred to as the “parties”.
FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF IOWA RESEARCH FOUNDATION AND VIEWPOINT MOLECULAR TARGETINGExclusive License Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus
This First Amendment ("First Amendment") is effective as of August 1, 2018 ("Effective Date"), and serves as a modification to the License Agreement ("Agreement") having an effective date of June 5, 2018, made by and between the University of Iowa Research Foundation ("UIRF"), and Viewpoint Molecular Targeting, Inc., a Delaware corporation with principal offices at 2500 Crosspark Road, UI BioVentures Center, El 16, Coralville, IA 52241 ("Licensee").
EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF IOWA RESEARCH FOUNDATION AND VIEWPOINT MOLECULAR TARGETINGExclusive License Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus • Iowa
This license agreement (“Agreement”) effective as of June 5, 2018 (“Effective Date”) is by and between the University of Iowa Research Foundation, a nonprofit corporation organized and existing under the laws of the State of Iowa and having an address at 112 N. Capitol Street, 6, Gilmore Hall, Iowa City, Iowa 52242 (“UIRF”), and Viewpoint Molecular Targeting, Inc., a Delaware corporation with principal offices at 2500 Crosspark Road, UI BioVentures Center, E116, Coralville, IA 52241 (“Licensee”).
SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF IOWA RESEARCH FOUNDATION AND VIEWPOINT MOLECULAR TARGETINGExclusive License Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Second Amendment ("Second Amendment") is effective as of November 1, 2019 ("Effective Date"), and serves as a modification to the License Agreement ("Agreement") having an effective date of June 5, 2018, as amended by a First Amendment having an effective date of August 1, 2018, made by and between the University of Iowa Research Foundation ("UIRF"), and Viewpoint Molecular Targeting, Inc., a Delaware corporation with principal offices at 2500 Crosspark Road, UI BioVentures Center, E116, Coralville, IA 52241 ("Licensee").
THIRD AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF IOWA RESEARCH FOUNDATION AND VIEWPOINT MOLECULAR TARGETINGExclusive License Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Third Amendment ("Third Amendment'") is effective as of January 30, 2020 ("Effective Date"'), and serves as a modification to the License Agreement ('·Agreement") having an effective date of June 5, 2018, as amended by a First Amendment having an effective date of August I, 2018, and a Second Amendment having an effective date of November I, 2019, made by and between the University of Iowa Research Foundation ("UIRF'"), and Viewpoint Molecular Targeting, lnc.. a Delaware corporation with principal offices at 2500 Crosspark Road, Ul Bio Ventures Center, E 116, Coralville, IA 52241 ("Licensee").
FOURTH AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF IOWA RESEARCH FOUNDATION AND VIEWPOINT MOLECULAR TARGETINGExclusive License Agreement • May 15th, 2023 • Perspective Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Fourth Amendment (“Fourth Amendment”) is effective as of June 12, 2020 (“Effective Date”), and serves as a modification to the License Agreement (“Agreement”) having an effective date of June 5, 2018, as amended by a First Amendment having an effective date of August 1, 2018, a Second Amendment having and effective date of November 1, 2019, and a Third Amendment having an effective date of January 30, 2020, made by and between the University of Iowa Research Foundation (“UIRF”), and Viewpoint Molecular Targeting, Inc., a Delaware corporation with principal offices at 2500 Crosspark Road, UI BioVentures Center, E116, Coralville, IA 52241 (“Licensee”).
